Action Moleculin Biotech - MBRX

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

1,70

Prix Achat

1,62

Prix Vente

1,82

Volume échangé

36 647

1,68 Fourchette du Jour 1,82

1,5002 Plage de 52 semaines 10,35

Cap du marché

5,103M

Clôture Veille

1,76

Ouverture

1,75

Dernière Transaction

1.82

Dernière heure de transaction

Volume financier

US$ 64 918

VWAP

1,7714

Volume moyen (3 m)

58 698

Actions en circulation

3 001 895

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,17

Bénéfice par action (BPA)

-9,92

Chiffre d'affairess

Bénéfice net

-29,77M

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Mod... Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.moleculin.com

Siège social

Wilmington, Delaware, USA

Fondé

Moleculin Biotech Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker MBRX. Le dernier cours de clôture d'Moleculin Biotech était de US$1,76. Au cours de la dernière année, les actions de Moleculin Biotech ont été négociées dans une fourchette de prix de US$ 1,5002 à US$ 10,35.

Moleculin Biotech compte actuellement 3 001 895 actions en circulation. La capitalisation boursière d'Moleculin Biotech est de US$5,28 million. Moleculin Biotech a un ratio cours/bénéfice (ratio PE) de -0.17.

Form 8-K - Current report

Moleculin Highlights Development Progress of Annamycin, Phase 2 Data Outperforms Billion-Dollar Assets in AML, Phase 3 Data Readouts in 2025 & 2026

Moleculin Highlights Development Progress of Annamycin, Phase 2 Data Outperforms Billion-Dollar Assets in AML, Phase 3 Data Readouts in 2025 & 2026 PR Newswire HOUSTON, Jan. 8, 2025 –...

Moleculin Announces Online Publication of Preclinical Data Demonstrating Significant Activity of Annamycin in Venetoclax Resistant AML Model

Moleculin Announces Online Publication of Preclinical Data Demonstrating Significant Activity of Annamycin in Venetoclax Resistant AML Model PR Newswire HOUSTON, Dec. 11, 2024 Abstract published...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.01	-0.584795321637	1.71	1.9279	1.7	26284	1.83344532	CS
4	-0.02	-1.16279069767	1.72	1.99	1.6	43155	1.76711438	CS
12	-0.86	-33.59375	2.56	3.33	1.5002	58698	2.31906679	CS
26	-1.77	-51.0086455331	3.47	3.7044	1.5002	47164	2.42121802	CS
52	-5.65	-76.8707482993	7.35	10.35	1.5002	59614	5.05731095	CS
156	-21.4	-92.6406926407	23.1	30.75	1.5002	111504	12.65323788	CS
260	-12.55	-88.0701754386	14.25	131.7	1.5002	909983	27.15834663	CS

MBRX - Frequently Asked Questions (FAQ)

What is the current Moleculin Biotech share price?

The current share price of Moleculin Biotech is US$ 1,70

How many Moleculin Biotech shares are in issue?

Moleculin Biotech has 3 001 895 shares in issue

What is the market cap of Moleculin Biotech?

The market capitalisation of Moleculin Biotech is USD 5,28M

What is the 1 year trading range for Moleculin Biotech share price?

Moleculin Biotech has traded in the range of US$ 1,5002 to US$ 10,35 during the past year

What is the PE ratio of Moleculin Biotech?

The price to earnings ratio of Moleculin Biotech is -0,17

What is the reporting currency for Moleculin Biotech?

Moleculin Biotech reports financial results in USD

What is the latest annual profit for Moleculin Biotech?

The latest annual profit of Moleculin Biotech is USD -29,77M

What is the registered address of Moleculin Biotech?

The registered address for Moleculin Biotech is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Moleculin Biotech website address?

The website address for Moleculin Biotech is www.moleculin.com

Which industry sector does Moleculin Biotech operate in?

Moleculin Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
EVAXEvaxion Biotech AS	US$ 5,99 (64,56%)	55,41M
ELABPMGC Holdings Inc	US$ 3,0901 (56,07%)	76,48M
PCLAPicoCELA Inc	US$ 4,60 (49,35%)	3,75M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
GODNUGolden Star Acquisition Corporation	US$ 3,11 (-75,82%)	17,51k
GODNGolden Star Acquisition Corporation	US$ 2,93 (-65,67%)	902,76k
NXTTNext Technology Holding Inc	US$ 1,37 (-54,93%)	2,56M
SGLYSingularity Future Technology Ltd	US$ 1,625 (-38,45%)	917,77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90,11 (-38,07%)	8
ACONAclarion Inc	US$ 0,0557 (28,94%)	811,91M
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
RIMEAlgorhythm Holdings Inc	US$ 0,0357 (4,69%)	284,97M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
NVDANVIDIA Corporation	US$ 142,62 (-3,12%)	232,88M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Moleculin Biotech Inc (MBRX) Cours

Moleculin Biotech Inc (MBRX)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Moleculin Biotech Inc

MBRX Dernières nouvelles

MBRX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application